Moderna (MRNA) is trading at $247.59 after a 2.79% pullback, even as the company’s third-quarter 2026 sales beat and raised full-year revenue guidance improved the fundamental backdrop. Analyst vie… (Read More)Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here